Skip to main content
. 2017 Apr 7;13(6):4558–4562. doi: 10.3892/ol.2017.6006

Figure 1.

Figure 1.

Effects of morusin on breast cancer cell viability. (A) MCF10A, (B) MCF-7, (C) MDA-MB-157, (D) MDA-MB-231 and (E) MDA-MB-453 cells were treated with morusin for 24, 48 and 72 h. Survival rate was determined using MTT assays. Data are presented as the mean ± standard error of the mean. *P<0.05; **P<0.01; and ***P<0.001 vs. mock-treated control.